{"success":true,"data":{"pressRelease":{"id":"163551","rtpr_id":"nGNX7SXNDr-20261007","ticker":"LFCR","exchange":"NASDAQ","all_tickers":["LFCR"],"title":"Lifecore Biomedical to Participate at Upcoming Industry Conferences","author":"Globe Newswire","published_at":"2026-10-07T20:05:00.324Z","article_body":"CHASKA, Minn., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc.\n(NASDAQ: LFCR\n(https://www.globenewswire.com/Tracker?data=x-OKa34849XtSdXpBBGisYsSUzSVe2D0rYXnE-Jm8xYfUywspqQXMJrujokVTR8Dts7edtVNsyGg2fxghShPahhoXg-TuQEtl7ci9PTLIvM=))\n(“Lifecore”), a fully integrated injectables contract development and\nmanufacturing organization (“CDMO”), today announced that the company will\nparticipate at three upcoming industry events. \n\nAt each conference, Lifecore leaders will host meetings with prospective\ncustomers to discuss process development and manufacturing services for\ninjectable programs.  Details regarding Lifecore’s participation are as\nfollows:\n* CDMO Live Americas:\nBooth number: C19 \nConference Dates: October 19-21, 2026\nLocation: Boston, MA\n\n\n* Partnership Opportunities in Drug Development (PODD)\nBooth number: 109 \nConference Dates: October 29-30, 2026\nLocation: Boston, MA\n\nRyan Swanson, Ph.D., director of Lifecore’s Manufacturing Science &\nTechnology (MS&T) group, will be a panel speaker at the following session: \nDesigning Devices to Deliver High-Dose/High Viscosity Peptides & Biologics\nFri, Oct 30 | 03:50 PM - 04:20 PM\nGrand Ballroom\n\n\n* American Pharma Manufacturing & Outsourcing Summit \nBooth number: TBD \nConference Dates: November 20-23, 2026\nLocation: Boston, MA\nIf you are interested in meeting with Lifecore during this event, please reach\nout to us at: cdmo@lifecore.com.\n\nAbout Lifecore Biomedical \nLifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract\ndevelopment and manufacturing organization (CDMO) that offers highly\ndifferentiated capabilities in the development, fill and finish of sterile\ninjectable pharmaceutical products in syringes, vials, and cartridges,\nincluding complex formulations. As a leading manufacturer of premium,\ninjectable-grade hyaluronic acid, Lifecore brings more than 40 years of\nexpertise as a partner for global and emerging biopharmaceutical and\nbiotechnology companies across multiple therapeutic categories to bring their\ninnovations to market. For more information about the company, visit\nLifecore’s website at www.lifecore.com.\n\nContact Information:\nVida Strategic Partners\nStephanie Diaz (Investors)\n415-675-7401\nsdiaz@vidasp.com\n\nJennifer Arcure (Media)\n917-603-0681\njarcure@vidasp.com\n\nLifecore Biomedical\nRyan D. Lake (CFO)\n952-368-6244\nryan.lake@lifecore.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/ca940278-cc18-4a3f-93b7-d8a034c998c9)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX7SXNDr-20261007","title":"Lifecore Biomedical to Participate at Upcoming Industry Conferences","author":"Globe Newswire","ticker":"LFCR","created":"2026-10-07T20:05:00.324Z","tickers":["LFCR"],"exchange":"NASDAQ","article_body":"CHASKA, Minn., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc.\n(NASDAQ: LFCR\n(https://www.globenewswire.com/Tracker?data=x-OKa34849XtSdXpBBGisYsSUzSVe2D0rYXnE-Jm8xYfUywspqQXMJrujokVTR8Dts7edtVNsyGg2fxghShPahhoXg-TuQEtl7ci9PTLIvM=))\n(“Lifecore”), a fully integrated injectables contract development and\nmanufacturing organization (“CDMO”), today announced that the company will\nparticipate at three upcoming industry events. \n\nAt each conference, Lifecore leaders will host meetings with prospective\ncustomers to discuss process development and manufacturing services for\ninjectable programs.  Details regarding Lifecore’s participation are as\nfollows:\n* CDMO Live Americas:\nBooth number: C19 \nConference Dates: October 19-21, 2026\nLocation: Boston, MA\n\n\n* Partnership Opportunities in Drug Development (PODD)\nBooth number: 109 \nConference Dates: October 29-30, 2026\nLocation: Boston, MA\n\nRyan Swanson, Ph.D., director of Lifecore’s Manufacturing Science &\nTechnology (MS&T) group, will be a panel speaker at the following session: \nDesigning Devices to Deliver High-Dose/High Viscosity Peptides & Biologics\nFri, Oct 30 | 03:50 PM - 04:20 PM\nGrand Ballroom\n\n\n* American Pharma Manufacturing & Outsourcing Summit \nBooth number: TBD \nConference Dates: November 20-23, 2026\nLocation: Boston, MA\nIf you are interested in meeting with Lifecore during this event, please reach\nout to us at: cdmo@lifecore.com.\n\nAbout Lifecore Biomedical \nLifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract\ndevelopment and manufacturing organization (CDMO) that offers highly\ndifferentiated capabilities in the development, fill and finish of sterile\ninjectable pharmaceutical products in syringes, vials, and cartridges,\nincluding complex formulations. As a leading manufacturer of premium,\ninjectable-grade hyaluronic acid, Lifecore brings more than 40 years of\nexpertise as a partner for global and emerging biopharmaceutical and\nbiotechnology companies across multiple therapeutic categories to bring their\ninnovations to market. For more information about the company, visit\nLifecore’s website at www.lifecore.com.\n\nContact Information:\nVida Strategic Partners\nStephanie Diaz (Investors)\n415-675-7401\nsdiaz@vidasp.com\n\nJennifer Arcure (Media)\n917-603-0681\njarcure@vidasp.com\n\nLifecore Biomedical\nRyan D. Lake (CFO)\n952-368-6244\nryan.lake@lifecore.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/ca940278-cc18-4a3f-93b7-d8a034c998c9)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-07T20:05:00.433411089Z","server_sent_at_ms":1791403500433},"received_at":"2026-10-07T20:05:00.936Z","source_url":null},"analysis":{"id":"152004","press_release_id":"163551","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Lifecore Biomedical announced it will participate at three upcoming industry conferences: CDMO Live Americas (Oct 19-21), PODD (Oct 29-30), and the American Pharma Manufacturing & Outsourcing Summit (Nov 20-23), all in Boston.\n\nAt PODD, Ryan Swanson, Ph.D., director of the MS&T group, will speak on a panel about designing devices to deliver high-dose/high-viscosity peptides and biologics.\n\nCompany leaders will host meetings with prospective customers to discuss process development and manufacturing services for injectable programs; no financial or business results were disclosed.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine conference-calendar notice for the CDMO; no material content."},"keyFigures":{},"namedEntities":{"people":[{"name":"Ryan Swanson, Ph.D.","role":"Director of Manufacturing Science & Technology (MS&T)"},{"name":"Ryan D. Lake","role":"CFO"}],"products":[],"companies":[{"name":"Lifecore Biomedical, Inc.","ticker":"LFCR","relationship":"filer"},{"name":"Vida Strategic Partners","relationship":"investor relations agency"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine announcement of conference participation and booth scheduling with no financial, regulatory, or contractual content."},"tickerRelevance":{"others":[],"primary":"LFCR"},"globalImportance":5,"audienceRelevance":5,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"conference-participation-notice","issuerAuthored":true}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Lifecore Biomedical announced it will participate at three upcoming industry conferences: CDMO Live Americas (Oct 19-21), PODD (Oct 29-30), and the American Pharma Manufacturing & Outsourcing Summit (Nov 20-23), all in Boston.\n\nAt PODD, Ryan Swanson, Ph.D., director of the MS&T group, will speak on a panel about designing devices to deliver high-dose/high-viscosity peptides and biologics.\n\nCompany leaders will host meetings with prospective customers to discuss process development and manufacturing services for injectable programs; no financial or business results were disclosed.","key_figures":{},"named_entities":{"people":[{"name":"Ryan Swanson, Ph.D.","role":"Director of Manufacturing Science & Technology (MS&T)"},{"name":"Ryan D. Lake","role":"CFO"}],"products":[],"companies":[{"name":"Lifecore Biomedical, Inc.","ticker":"LFCR","relationship":"filer"},{"name":"Vida Strategic Partners","relationship":"investor relations agency"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-07T20:05:07.476Z","global_importance":5,"audience_relevance":5,"importance_components":{"tickerTier":"small-cap","eventGravity":"conference-participation-notice","issuerAuthored":true}},"durationMs":3611,"modelName":"glm-5.3-flashx"}}